Evidence-Based Neuroethics, Deep Brain Stimulation and Personality - Deflating, but not Bursting, the Bubble.
Agency
Authenticity
Autonomy
Deep brain stimulation
Evidence-based medicine
Identity
Personality
Self
Surgical trials
Journal
Neuroethics
ISSN: 1874-5490
Titre abrégé: Neuroethics
Pays: Netherlands
ID NLM: 101468977
Informations de publication
Date de publication:
2021
2021
Historique:
received:
10
09
2018
accepted:
18
11
2018
entrez:
18
11
2021
pubmed:
19
11
2021
medline:
19
11
2021
Statut:
ppublish
Résumé
Gilbert et al. have raised important questions about the empirical grounding of neuroethical analyses of the apparent phenomenon of Deep Brain Stimulation 'causing' personality changes. In this paper, we consider how to make neuroethical claims appropriately calibrated to existing evidence, and the role that philosophical neuroethics has to play in this enterprise of 'evidence-based neuroethics'. In the first half of the paper, we begin by highlighting the challenges we face in investigating changes to PIAAAS following DBS, explaining how different trial designs may be of different degrees of utility, depending on how changes to PIAAAS following DBS are manifested. In particular, we suggest that the trial designs Gilbert et al. call for may not be able to tell us whether or not DBS directly causes changes to personality. However, we suggest that this is not the most significant question about this phenomenon; the most significant question is whether these changes should matter morally, however they are caused. We go on to suggest that neuroethical analyses of novel neuro-interventions should be carried out in accordance with the levels of evidence hierarchy outlined by the Centre for Evidence-Based Medicine (CEBM), and explain different ways in which neuroethical analyses of changes to PIAAAS can be evidence-based on this framework. In the second half of the paper, we explain how philosophical neuroethics can play an important role in contributing to mechanism-based reasoning about potential effects on PIAAAS following DBS, a form of evidence that is also incorporated into the CEBM levels of evidence hierarchy.
Identifiants
pubmed: 34790274
doi: 10.1007/s12152-018-9392-5
pii: 9392
pmc: PMC8568854
doi:
Types de publication
Journal Article
Langues
eng
Pagination
27-38Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203195/Z/16/Z
Pays : United Kingdom
Informations de copyright
© The Author(s) 2018.
Déclaration de conflit d'intérêts
Conflict of InterestT.A. is a paid consultant for Boston Scientific, Medtronic and St. Jude Medical. He has received honoraria from Abbott, Boston and Medtronics and served as consultant to all three.
Références
Neurology. 2004 Jan 27;62(2):201-7
pubmed: 14745054
Behav Res Ther. 2014 Nov;62:47-59
pubmed: 25151600
BMJ. 1996 Jan 13;312(7023):71-2
pubmed: 8555924
Neurology. 2006 Jun 27;66(12):1811-6
pubmed: 16801642
N Engl J Med. 2000 Feb 17;342(7):461-8
pubmed: 10675426
Lancet Psychiatry. 2017 Apr;4(4):285-294
pubmed: 28238701
Camb Q Healthc Ethics. 2017 Oct;26(4):640-657
pubmed: 28937346
PLoS One. 2017 Apr 20;12(4):e0175748
pubmed: 28426824
Front Psychiatry. 2018 Oct 26;9:523
pubmed: 30416458
Neuroethics. 2015;8(3):215-230
pubmed: 26594256
Br J Psychiatry. 2019 Mar;214(3):133-136
pubmed: 30774052
Neuroethics. 2013;6:483-497
pubmed: 24273619
Front Integr Neurosci. 2015 Apr 02;9:27
pubmed: 25883557
Parkinsons Dis. 2017;2017:9358153
pubmed: 28951797
Front Psychiatry. 2018 Apr 06;9:24
pubmed: 29681866
J Neural Transm Suppl. 2006;(70):409-14
pubmed: 17017560
Front Psychiatry. 2017 Mar 20;8:44
pubmed: 28373849